Zum Inhalt springen
HPB-ALL
Gewebe
Peripheral blood
Krankheit
Precursor T-cell acute lymphoblastic leukemia
Metastasenherd
Peripheral blood (systemic T-ALL)
Synonyme
HPB/ALL, HPBALL, FCCH1018

Dokumente

HPB-ALL

Cell line · Artikelnummer 302895

HPB-ALL ist eine Zelllinie der akuten lymphoblastischen T-Zell-Leukämie (T-ALL) beim Menschen, die aus dem peripheren Blut eines 14-jährigen japanischen Jungen gewonnen wurde...

€430.00zzgl. MwSt. und Versandkosten

Anpassung / Empfehlungen

Auf Lager
Charge
Empfohlen (frischeste Charge)
  • CoA
1

01Allgemeine Informationen

Beschreibung

HPB-ALL is a human precursor T-cell acute lymphoblastic leukemia (T-ALL) cell line established from the peripheral blood of a 14-year-old Japanese male patient. The line grows in suspension with lymphocyte-like morphology. HPB-ALL harbors a complex TP53 mutational profile with eight mutations across heterozygous and homozygous states, reflecting the genetic complexity of T-ALL at diagnosis. The line expresses T cell surface markers consistent with T-ALL biology, making it relevant for studies of T lymphoblast leukemia pathogenesis and drug responses.

HPB-ALL is applicable in studies of T-ALL biology, TP53 multi-mutant phenotype, anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine), Notch and JAK-STAT pathway analysis, and comparative studies within the T-ALL cell line panel. It is suitable for in vitro pharmacological assays and xenograft models in immunocompromised hosts for preclinical T-ALL drug evaluation. Doubling time approximately 50 hours.

Gewebe
Peripheral blood
Krankheit
Precursor T-cell acute lymphoblastic leukemia
Metastasenherd
Peripheral blood (systemic T-ALL)
Anwendungen
T-ALL biology; TP53 multi-mutant phenotype; anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine); Notch/JAK-STAT pathways; xenograft models; T-ALL panel comparative studies
Synonyme
  • HPB/ALL
  • HPBALL
  • FCCH1018

02Klassifizierung

Organismus
Mensch
Sex
Männlich
Wachstumseigenschaften
Aussetzung
Biologische Sicherheitsstufe
1

03Merkmale

Morphologie
Lymphoblast-like
Zelltyp
T-cell
Verdopplungszeit
~50 hours

04Bezeichner

Quellenangabe
HPB-ALL (Cytion catalog number 302895)
NCBI-Steuer-ID
9606
Cellosaurus
CVCL_1820

05Expression und Anfälligkeit

Mutationsprofil
Mutation: p.Arg465His, Unspecified; Mutation: p.Ala134Ser, Unspecified; Mutation: p.Leu1574Pro, Heterozygous; Mutation: p.Asp2442fs*39, Heterozygous; Mutation: p.Arg159Ser, Unspecified; Mutation: p.Cys124Ter, Homozygous; Mutation: p.Arg273Cys, Unspecified; Mutation: p.Ser121Ter, Unspecified

06Handhabung und Kultur

Nährmedium
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Nahrungsergänzungsmittel
Supplement the medium with 10% FBS
Dissoziationsreagenz
dilution
Subkultivierung
Dilute the culture to 2–5 × 10⁵ cells/ml with fresh pre-warmed complete medium twice per week. No enzymatic dissociation required.
Split-Verhältnis
1 : 10 split
Aussaatdichte
3-5*10^5/ml
Flüssigkeitswechsel
Subculture : 2 times/week
Auftauen und Kultivierung
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

07Qualitätskontrolle und Kryokonservierung

Gefriermedium
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Lagerbedingungen

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Versandbedingungen

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Spender

Alter des Spenders
14 years
Ethnische Zugehörigkeit
Japanese

10Produktdetails

Zusammensetzungstabelle